Get the Stockscreener App
0.1502
0.81%
0.0012
After Hours:
.15
-0.0002
-0.13%
Calidi Biotherapeutics Inc Stock (CLDI) Forecast
The Calidi Biotherapeutics Inc (CLDI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.13, representing a +7,308% increase from the current price of $0.1502. The highest analyst price target is $11.11, and the lowest is $11.14.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CLDI Price Target
Average 7.9908
(+5,220% Upside)
Is Calidi Biotherapeutics Inc (CLDI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.11 | Neutral |
| STOCH(9,6) | 48.28 | Neutral |
| STOCHRSI(14) | 66.54 | Neutral |
| MACD(12,26) | -0.00923 | Buy |
| ADX(14) | 28.34 | Sell |
| William %R | -43.43 | Neutral |
| CCI(14) | -12.47 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.1596
Sell
|
0.1614
Sell
|
| MA20 |
0.1634
Sell
|
0.1661
Sell
|
| MA50 |
0.1866
Sell
|
0.2165
Sell
|
| MA100 |
0.3316
Sell
|
0.4527
Sell
|
| MA200 |
0.8572
Sell
|
1.4508
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CLDI could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on CLDI, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.11 indicates that CLDI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 48.28 indicates that CLDI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 66.54 indicates that CLDI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.34 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -12.47 indicates that CLDI is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CLDI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Calidi Biotherapeutics Inc financial reports and earnings history, Calidi Biotherapeutics Inc (CLDI) stock could reach $7.7302 by 2030, $42.91 by 2040 and $104.99 by 2050. See the projected annual prices until 2050 of the Calidi Biotherapeutics Inc stock below:
- Calidi Biotherapeutics Inc (CLDI) is expected to reach an average price of $16.63 in 2035, with a high prediction of $22.22 and a low estimate of $16.69. This indicates an $10,969% rise from the last recorded price of $0.1502.
- Calidi Biotherapeutics Inc (CLDI) stock is projected to chart a bullish course in 2040, with an average price target of $37.27, representing an $24,713% surge from its current level. The forecast ranges from a conservative $37.35 to a sky-high $42.91.
- Our analysts predict Calidi Biotherapeutics Inc (CLDI) to jump 41,670% by 2045, soaring from $62.89 to an average price of $62.74, potentially reaching $70.21. While $62.89 is the low estimate, the potential upside is significant.
- Calidi Biotherapeutics Inc (CLDI) stock is expected to climb by 2050, reaching an average of $94.90, a $63,085% jump from its current level. However, a wide range of estimates exists, with high and low targets of $104.99 and $95.15, respectively, highlighting the market's uncertainty.
Calidi Biotherapeutics Inc Stock (CLDI) Year by Year Forecast
Calidi Biotherapeutics Inc Stock (CLDI) Price Forecast for 2026
The predicted value for Calidi Biotherapeutics Inc (CLDI) in 2026 is set at an average of $6.0004. Estimates vary from a peak of $11.33 to a trough of $0.6661, indicating an +3,895% surge from the present price of $0.1502.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2026 | $10.93 | $11.14 | $11.11 | +7,176% |
| September, 2026 | $9.0748 | $9.4348 | $10.58 | +5,942% |
| October, 2026 | $7.9582 | $8.0149 | $8.5582 | +5,198% |
| November, 2026 | $6.9616 | $6.9716 | $7.5516 | +4,535% |
| December, 2026 | $5.6013 | $5.6663 | $6.605 | +3,629% |
Calidi Biotherapeutics Inc Stock (CLDI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Calidi Biotherapeutics Inc (CLDI) is $9.9193, with a high forecast of $18.89 and a low forecast of $0.9466. This indicates an +6,504% increase from the last price of $0.1502.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.9707 | $4.0392 | $4.3284 | +2,544% |
| February, 2027 | $2.659 | $2.6601 | $3.5151 | +1,670% |
| March, 2027 | $1.3925 | $0.9466 | $1.8385 | +827.11% |
| April, 2027 | $14.70 | $14.94 | $15.03 | +9,684% |
| May, 2027 | $13.95 | $14.40 | $14.20 | +9,189% |
| June, 2027 | $11.30 | $11.55 | $13.35 | +7,420% |
| July, 2027 | $10.04 | $10.18 | $10.37 | +6,586% |
| August, 2027 | $8.6487 | $8.7738 | $9.5386 | +5,658% |
| September, 2027 | $6.1721 | $6.7021 | $8.1354 | +4,009% |
| October, 2027 | $4.6319 | $4.6933 | $5.5755 | +2,984% |
| November, 2027 | $2.6408 | $2.9556 | $4.0884 | +1,658% |
| December, 2027 | $19.09 | $1.227 | $18.89 | +12,611% |
Calidi Biotherapeutics Inc Stock (CLDI) Price Forecast for 2028
In 2028, Calidi Biotherapeutics Inc (CLDI) is projected to reach an average price of $12.13, with a high projection of $22.75 and a low estimate of $1.5075. This indicates an +7,975% rise from the last price of $0.1502.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $18.21 | $18.42 | $18.76 | +12,025% |
| February, 2028 | $16.50 | $16.59 | $17.31 | +10,887% |
| March, 2028 | $13.47 | $13.70 | $15.38 | +8,870% |
| April, 2028 | $11.82 | $11.97 | $12.62 | +7,771% |
| May, 2028 | $9.5826 | $9.6625 | $11.09 | +6,280% |
| June, 2028 | $7.4656 | $7.4656 | $8.9798 | +4,870% |
| July, 2028 | $5.1626 | $5.1826 | $6.8226 | +3,337% |
| August, 2028 | $2.6821 | $2.6993 | $4.5407 | +1,686% |
| September, 2028 | $23.00 | $1.5075 | $22.75 | +15,211% |
| October, 2028 | $21.27 | $21.27 | $22.33 | +14,058% |
| November, 2028 | $18.43 | $18.53 | $20.31 | +12,172% |
| December, 2028 | $15.53 | $15.53 | $17.27 | +10,237% |
Calidi Biotherapeutics Inc Stock (CLDI) Price Forecast for 2029
The 2029 price forecast for Calidi Biotherapeutics Inc Stock (CLDI) is $14.20 on average, with a high prediction of $26.61 and a low estimate of $1.788. This represents an +9,352% increase from the previous price of $0.1502.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $13.02 | $13.03 | $14.81 | +8,570% |
| February, 2029 | $10.85 | $10.90 | $12.38 | +7,125% |
| March, 2029 | $8.1024 | $8.1297 | $9.9196 | +5,294% |
| April, 2029 | $5.4581 | $5.4657 | $7.253 | +3,534% |
| May, 2029 | $2.4449 | $2.48 | $4.7165 | +1,528% |
| June, 2029 | $26.39 | $1.788 | $26.61 | +17,470% |
| July, 2029 | $24.04 | $24.27 | $25.38 | +15,903% |
| August, 2029 | $20.25 | $20.61 | $23.30 | +13,382% |
| September, 2029 | $17.59 | $17.67 | $19.35 | +11,609% |
| October, 2029 | $14.42 | $14.55 | $16.79 | +9,500% |
| November, 2029 | $11.75 | $11.81 | $13.62 | +7,723% |
| December, 2029 | $8.5725 | $8.641 | $10.08 | +5,607% |
Calidi Biotherapeutics Inc Stock (CLDI) Price Forecast for 2030
Calidi Biotherapeutics Inc Stock (CLDI) is expected to reach an average price of $18.19 in 2030, with a high forecast of $34.32 and a low forecast of $2.0684. This signifies an +12,013% surge from the last price of $0.1502.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.6421 | $4.9569 | $7.7302 | +2,991% |
| February, 2030 | $2.946 | $2.0684 | $3.8236 | +1,861% |
| March, 2030 | $28.96 | $29.20 | $30.46 | +19,183% |
| April, 2030 | $26.67 | $27.12 | $28.08 | +17,658% |
| May, 2030 | $22.08 | $22.33 | $25.68 | +14,603% |
| June, 2030 | $19.28 | $19.42 | $20.77 | +12,739% |
| July, 2030 | $15.64 | $15.64 | $18.39 | +10,315% |
| August, 2030 | $11.93 | $12.46 | $14.77 | +7,845% |
| September, 2030 | $8.8469 | $8.9083 | $10.56 | +5,790% |
| October, 2030 | $4.9721 | $4.9791 | $7.9169 | +3,210% |
| November, 2030 | $34.52 | $2.3489 | $34.32 | +22,883% |
| December, 2030 | $32.09 | $32.30 | $33.80 | +21,267% |
0.05%
0.74%
Cap:
|
Volume (24h):